We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNahl Group Regulatory News (NAH)

Share Price Information for Nahl Group (NAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 65.50
Ask: 69.50
Change: 0.50 (0.75%)
Spread: 4.00 (6.107%)
Open: 65.00
High: 65.00
Low: 65.00
Prev. Close: 67.00
NAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

21 Sep 2016 07:00

RNS Number : 3748K
NAHL Group PLC
21 September 2016
 

21 September 2016

 

NAHL Group plc

("NAHL" or the "Group")

 

Interim Results

 

Performance in line with expectations led by strong growth in Critical Care division

 

NAHL, the leading UK marketing and services business focused on the UK consumer legal market, announces its Interim Results for the six months ended 30 June 2016.

 

Financial Highlights

Revenue up 1.3% to £25.8m (2015 H1: £25.4m)

Underlying operating profit up 24.5% to £8.8m (2015 H1: £7.0m)

Improvement in underlying operating profit margin from 27.7% to 34.0%

Profit before tax up 17.1% to £7.5m (2015 H1: £6.4m)

Excellent cash conversion of 95.7% (2015 H1: 95.5%)

Basic earnings per share up 5.6% to 13.2p (2015 H1: 12.5p)

Interim dividend of 6.35p per share (2015 H1: 6.25p)

 

Operational Highlights

Focus on a higher value blend of cases in Personal Injury division, NAH, with strengthened margins, despite an uncertain regulatory backdrop

 

Further progress with strategic diversification into complementary legal services markets

 

Bush, the Group's Critical Care division, has performed well and is trading ahead of plan

 

Fitzalan, the Group's Conveyancing division, has shown good organic growth in revenue and operating profits

Searches UK acquisition extends the conveyancing offering

 

Russell Atkinson, CEO of NAHL, commented:

 

"I am pleased to report a solid performance in the first half of the year, as the more diversified nature of the Group helped to drive improvements in our profitability. We saw a strong contribution from Bush, the Group's Critical Care division, whilst our conveyancing business also showed good organic revenue and profit growth, strengthened by the performance of Searches UK, which was acquired in January.

"NAH performed as expected, with our deliberate strategy to reduce volumes and focus on higher value case types helping to improve margins. We continue to plan for a range of outcomes as we await the anticipated publication of the Ministry of Justice's consultation.

 

"The underlying performance of the Group continues to benefit from our strategic diversification into complementary legal services markets and we have continued to make good progress on achieving our vision of being the UK's leading marketing and services provider in our chosen legal markets. The Group continues to deliver good levels of cash generation and the Board remains committed to a progressive dividend policy. Second half trading has commenced in line with our expectations."

 

Enquiries:

NAHL Group plc

Russell Atkinson (CEO)

Steve Dolton (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Investec Bank plc (NOMAD & Broker)

Garry Levin

David Flin

James Ireland

David Anderson

William Godfrey

 

Tel: +44 (0) 20 7597 5970

FTI Consulting (Financial PR)

Oliver Winters

Alex Beagley

James Styles

 

Tel: +44 (0) 20 3727 1000

Notes to Editors

 

NAHL Group

 

NAHL Group plc is a leading UK marketing and services business focused on the UK consumer legal market. The Group comprises three divisions: Personal Injury (National Accident Helpline - NAH), Conveyancing (Fitzalan Partners - Fitzalan) and Ctitical Care (Bush & Company Rehabilitation - Bush). NAH provides outsourced marketing services in the personal injury market, Fitzalan, which includes Searches UK a leading conveyancing search provider, provides marketing services in the property market and Bush provides a range of specialist services in the catastrophic injury market.

More information is available at www.nahlgroupplc.co.uk and www.national-accident-helpline.co.uk

 

Chairman's Statement

 

I am pleased to report the Group's results for the six months ended 30 June 2016.

 

Summary of Financial Performance

 

NAHL Group plc ("NAHL" or "the Group") has performed in line with expectations, with revenue of £25.8m, up 1.3% (2015 H1: £25.4m), delivering underlying operating profit1 of £8.8m, up 24.5% (2015 H1: £7.0m). Profit before tax increased 17.1% to £7.5m, up from £6.4m and basic earnings per share were 13.2p, up 5.6% from 12.5p in the comparative period in 2015.

 

Trading Review

 

National Accident Helpline ("NAH"), the Group's Personal Injury ("PI") division, has performed as we expected and the NAH brand continues to rank as the most trusted and recognised in the PI sector. As previously highlighted, we have purposefully reduced case volumes, whilst the current regulatory uncertainty causes law firms to consider more carefully how much they invest in new PI cases. It is encouraging to note that the reduction in activity by our Panel Law Firms ("PLFs") has been in line with our expectations and demand appears to have stabilised through the period. In reducing our case volumes, we have proactively focused on a higher value blend of cases, which are attractive to our PLFs. As a result while our revenue has reduced, as planned, by 33.7%, margins have been strengthened and operating profits are only 6.8% lower than the same period last year. This is a creditable performance given the regulatory backdrop. We plan to maintain the current levels of operating performance in the second half of this financial year.

 

We still await the publication of the consultation, announced in the Chancellor's Autumn Statement in November 2015, into, inter alia, the potential transfer of PI claims of up to £5,000 to the small claims court and the removal of the right of individuals to claim general damages for minor whiplash injuries. Regrettably this has not yet been published and appears to have suffered further delays following the EU Referendum. We continue to plan for a range of potential outcomes which we expect will be implemented in H2 2017 at the earliest. As part of our planning, we are building closer relationships with our key PLFs, and would expect that the new regulatory environment, when it emerges, will give us the opportunity to play a more pro-active role in the entire conduct and financing of a PI case. We intend to trial an initial small proportion of our enquiries in the final quarter of 2016 through different commercial and structural arrangements to those we normally deploy and will provide an update on this initiative at the Group's full year results.

 

Fitzalan, the Group's Conveyancing division, has shown good organic growth in revenue and operating profits in the first half, complemented by the acquisition of Searches UK in January 2016. The division operates in the UK residential property transactional market and is well placed to grow as consumer habits for procuring legal services continue to change. While we have seen reduced volumes in the immediate aftermath of the EU Referendum these volumes have started to recover more recently albeit from a low base and we expect to maintain our first half performance through the rest of the year. We remain confident of the longer-term outlook for the division.

 

Bush, the Group's Critical Care division acquired in October 2015, has performed well and is trading ahead of plan. Revenue of £5.2m has delivered operating profit of £1.8m. Our investment in business development has proved timely and new business initiatives are progressing as planned. We continue to invest in our quality reputation and therefore clinical independence is reinforced. We expect to see continued growth in the second half of this financial year.

 

Balance Sheet and Cash Conversion

 

Cash generation was again strong across NAHL, with a 95.7% (2015 H1: 95.5%) cash conversion of underlying operating profit into net cash flows from continuing operating activities before interest and tax. Whilst we expect this percentage to decline in the second half we still expect a good level of cash generation moving forward. Our balance sheet is robust and at the period end we had adjusted net debt2 of £9.6m, an increase of £1.3m since the year end, after paying the 2015 final dividend of £5.7m and cash consideration of £2.1m for the acquisition of Searches UK in January 2016.

 

We intend to utilise some of our strong cash flow to fund the trial of a small proportion of our enquiries through different commercial and structural arrangements, at NAH, as indicated above. Whilst these trials will result in a reduction in our cash conversion at NAHL, we believe it will underpin an accelerated start into any new regulated environment. Our dividend policy remains unaffected by this.

 

Interim Dividend

 

The Board has declared an interim dividend of 6.35p per share payable on 31 October 2016 to ordinary shareholders registered on 30 September 2016.

 

Outlook

 

At the Group level, second half trading has commenced in line with our expectations despite facing short term headwinds in both our PI and Conveyancing markets, both created by unusual and disruptive events.

 

Progress is unlikely to be seen in the PI division until the regulatory position starts to clarify and we can begin implementing plans for the future. We have right sized NAH to reflect the uncertain regulatory environment. The strategic decision to focus on higher value cases within NAH as well as our digital expertise, market leadership and brand recognition, means we remain well placed to capitalise on any emerging opportunities to ensure consumers continue to access justice fairly and cost effectively.

 

We expect our Conveyancing division to trade in line with first half performance, despite continued market volatility, and the Board expects to see growth in 2017 as confidence in the UK transactional market stabilises.

 

Our Critical Care division continues to trade well and we are optimistic about further growth prospects for this division.

 

Whilst we have had to deal with a number of market related issues in the year so far, overall, we expect 2016 to be a year of progress.

 

Steve Halbert

Chairman

 

20 September 2016

 

1

Underlying operating profit excludes share based payments, amortisation of intangible assets acquired on business combination and one-off items

2

Adjusted net debt comprises cash and cash equivalents, borrowings and other payables relating to a discontinued pre- LASPO product.

 

Management Report

 

NAHL is a leading UK marketing and services business focused on the UK consumer legal market. The Group comprises three divisions: Personal Injury (National Accident Helpline), Conveyancing (Fitzalan Partners and Searches UK) and Critical Care (Bush and Company Rehabilitation).

 

The Group has shown good growth in the period with Personal Injury performing as expected with good contributions from Conveyancing and particularly Critical Care which has performed ahead of plan.

 

Financial Overview

 

Revenue

Revenue increased by 1.3% to £25.8m (2015 H1: £25.4m). Within this, Critical Care, which was acquired in October 2015, contributed £5.2m (2015 H1: £nil). Revenue in Personal Injury, as anticipated, declined as we adjusted our model to focus on higher yielding enquiries.

 

Profitability

Underlying operating profit increased by 24.5% to £8.8m (2015 H1: £7.0m).

 

Personal Injury, as expected, showed a 6.8% decline to £7.0m (2015 H1: £7.5m) as the market continued to react to the Chancellor's Autumn Statement, made in November 2015, regarding potential changes in the small claims limit and general damages in RTA. Whilst the number of enquiries and therefore revenue declined, the division did optimise its marketing spend and delivered good margin improvement.

 

Conveyancing continued its good start since joining the Group in February 2015. With the acquisition of Searches UK in January 2016 the division has seen its operating profit increase by 113.4% to £0.7m (2015 H1: £0.3m). Whilst the division, in line with the market as a whole, has seen a slowdown in activity since the EU referendum we believe the division will still produce good growth this year.

 

Critical Care has made an excellent start delivering £1.8m of operating profit (2015 H1: £nil). The division has supplemented key operational management and increased overall staff numbers to underpin its strong quality ethos. It has also strengthened its business development activities and the Group is confident that the division will continue to increase its market share in this sector.

 

The Group remains committed to maintaining cost controls and has delivered an improvement in the underlying operating profit margin from 27.7% to 34.0%. Non underlying items of £1.0m (2015 H1: £0.5m) mainly relate to amortisation of intangible assets and share based costs.

 

Earnings per Share

Basic and diluted earnings per share for the period were 13.2p and 12.9p respectively (2015 H1: 12.5p and 12.3p).

 

Dividend

The Board has declared an interim dividend of 6.35p per ordinary share (2015 H1: 6.25p) which will be paid on 31 October 2016 to ordinary shareholders registered at the close of business on 30 September 2016. The policy to pay two thirds of its retained earnings each year, with one third of this at the interim stage, as a dividend remains the board's objective. The final payment is expected to be announced in March 2017 for payment in May 2017.

 

Cash and Balance Sheet

The Group had £9.6m of adjusted net debt at 30 June 2016 (2015 H1: £1.2m). This comprised the following:

 

 30 June 2016

£000

30 June 2015

£000

31 December 2015

£000

Cash and cash equivalents

6,522

9,324

10,056

Other interest-bearing loans and loan notes

(12,936)

(5,901)

(14,782)

Net (debt)/cash

(6,414)

3,423

(4,726)

Other payables relating to pre LASPO ATE product

(3,167)

(4,610)

(3,601)

Adjusted net debt

(9,581)

(1,187)

(8,327)

 

 

The Group continued to enjoy strong cash flow from operating activities and delivered a cash conversion of underlying operating profit into net cash flows from continuing operating activities before interest and tax of 95.7% (2015 H1: 95.5%).Whilst the overall percentage will see a decline in the second half we still expect the Group to deliver good levels of cash generation. The overall increase in adjusted net debt since June 2015 was primarily due to the acquisition of Bush and Company Rehabilitation in October 2015 which was partly funded from cash.

 

 

Russell Atkinson

Chief Executive Officer

 

Steve Dolton

Chief Financial Officer

 

20 September 2016

 

 

Consolidated statement of comprehensive income

for the 6 months ended 30 June 2016

 

 

 

 

 

 

Note

Unaudited 6 months ended 30 June 2016 £000

 

 

Unaudited 6 months ended 30 June 2015 £000

 

Audited 12 months ended 31 December 2015

£000

Revenue

2

25,753

25,411

50,716

Cost of sales

(10,991)

(13,911)

(25,785)

Gross profit

14,762

11,500

24,931

Administrative expenses

(7,034)

(5,014)

(10,812)

Underlying operating profit

8,750

7,030

15,622

Share-based payments

(433)

(374)

(833)

Amortisation of intangible assets acquired on business combination

8

(533)

-

(259)

One-off items

5

(56)

(170)

(411)

Total operating profit

2

7,728

6,486

14,119

Financial income

3

10

35

59

Financial expense

4

(209)

(90)

(228)

Profit before tax

7,529

6,431

13,950

Taxation

(1,563)

(1,287)

(3,184)

Profit for the year and total comprehensive income

5,966

5,144

10,766

 

All profits and losses and total comprehensive income are attributable to the owners of the Company.

 

Unaudited 6 months ended 30 June 2016

Unaudited 6 months ended 30 June 2015

Audited 12 months ended 31 December 2015

Basic earnings per share (p)

11

13.2

12.5

25.6

Diluted earnings per share (p)

11

12.9

12.3

25.0

 

Consolidated statement of financial position

At 30 June 2016

 

Note

Unaudited 6 months ended 30 June 2016

£000

Unaudited 6 months ended 30 June 2015

£000

Audited 12 months ended 31 December 2015

£000

Non-current assets

Goodwill

7

60,362

43,726

59,238

Intangibles

8

8,780

484

8,452

Property, plant and equipment

339

105

259

Deferred tax asset

68

78

68

69,549

44,393

68,017

Current assets

Trade and other receivables

9,235

5,658

8,044

Cash and cash equivalents

6,522

9,324

10,056

15,757

14,982

18,100

Total assets

85,306

59,375

86,117

Current liabilities

Other interest-bearing loans and borrowings

(3,693)

(2,950)

(3,693)

Trade and other payables

(9,557)

(10,155)

(8,949)

Other payables relating to legacy pre-LASPO ATE product

2

(3,167)

(4,610)

(3,601)

Deferred tax liability

(1,916)

(101)

(1,738)

Tax payable

(1,909)

(1,319)

(1,976)

(20,242)

(19,135)

(19,957)

Non-current liabilities

Other interest-bearing loans and borrowings

(9,243)

(2,951)

(11,089)

Total liabilities

(29,485)

(22,086)

(31,046)

Net assets

55,821

37,289

55,071

Equity

Share capital

9

113

103

113

Share option reserve

1,554

662

1,121

Share premium

14,271

-

14,262

Merger reserve

(66,928)

(66,928)

(66,928)

Retained earnings

106,811

103,452

106,503

Total equity

55,821

37,289

55,071

 

 Consolidated statement of changes in equity

for the 6 months ended 30 June 2016

 

Share

capital

£000

Share

option

reserve

£000

Share

premium

£000

Merger

reserve

£000

Retained

earnings

£000

Total

equity

£000

Balance at 1 January 2016

113

1,121

14,262

(66,928)

106,503

55,071

Total comprehensive income for the period

Profit for the period

-

-

-

-

5,966

5,966

Total comprehensive income for the period

-

-

-

-

5,966

5,966

Transactions with owners, recorded directly in equity

Issue of new Ordinary Shares (note 10)

-

-

9

-

-

9

Share-based payments

-

433

-

-

-

433

Dividends paid

-

-

-

-

(5,658)

(5,658)

Balance at 30 June 2016

113

1,554

14,271

(66,928)

106,811

55,821

Balance at 1 January 2015

103

288

49,533

(50,000)

36,250

36,174

Total comprehensive income for the period

Profit for the year

-

-

-

-

5,144

5,144

Total comprehensive income

-

-

-

-

5,144

5,144

Transactions with owners, recorded directly in equity

Bonus issue of Capital reduction shares

16,928

-

-

(16,928)

-

-

Capital reduction shares cancelled

(16,928)

-

-

-

16,928

-

Capital reduction

-

-

(49,533)

-

49,533

-

Share-based payments

-

374

-

-

-

374

Dividends paid

-

-

-

-

(4,403)

(4,403)

Balance at 30 June 2015

103

662

-

(66,928)

103,452

37,289

Balance at 1 January 2015

103

288

49,533

(50,000)

36,250

36,174

Total comprehensive income for the period

Profit for the year

-

-

-

-

10,766

10,766

Total comprehensive income

-

-

-

-

10,766

10,766

Transactions with owners, recorded directly in equity

Bonus issue of Capital reduction shares

16,928

-

-

(16,928)

-

-

Capital reduction shares cancelled

(16,928)

-

-

-

16,928

-

Capital reduction

-

-

(49,533)

-

49,533

-

Issue of new Ordinary Shares

10

-

14,262

-

-

14,272

Share-based payments

-

833

-

-

-

833

Dividends paid

-

-

-

-

(6,974)

(6,974)

Balance at 31 December 2015

113

1,121

14,262

(66,928)

106,503

55,071

Consolidated cash flow statement

for the period ended 30 June 2016

 

Note

Unaudited 6 months ended 30 June 2016

£000

Unaudited 6 months ended 30 June 2015 £000

Audited 12 months ended 31 December 2015

£000

Cash flows from operating activities

Profit for the year

5,966

5,144

10,766

Adjustments for:

Depreciation and amortisation

619

104

436

Financial income

3

(10)

(35)

(59)

Financial expense

4

209

90

228

Share-based payments

433

374

833

Taxation

1,563

1,287

3,184

8,780

6,964

15,388

Increase in trade and other receivables

(823)

(1,792)

(813)

Increase in trade and other payables

364

1,380

226

Decrease in other payables relating to legacy pre-LASPO ATE product

(434)

(1,901)

(2,910)

Cash generation from operations

2

7,887

4,651

11,891

Interest paid

4

(209)

(90)

(216)

Tax paid

(1,735)

(1,464)

(3,127)

Net cash from operating activities

5,943

3,097

8,548

 

Cash flows from investing activities

Acquisition of property, plant and equipment

(151)

(6)

(195)

Consideration paid for the acquisition of subsidiaries

(2,091)

(3,662)

(33,681)

Intangible assets acquired

(14)

-

(51)

Cash acquired from business combination

293

626

5,572

Interest received

3

10

35

59

Net cash used in investing activities

(1,953)

(3,007)

(28,296)

 

Cash flows from financing activities

New share issue

9

-

14,272

Repayment of borrowings

(1,875)

-

(5,901)

New borrowings acquired

-

-

15,000

Bank arrangement fees for new borrowings

-

-

(230)

Dividends paid

(5,658)

(4,403)

(6,974)

Net cash used in financing activities

(7,524)

(4,403)

(16,167)

 

Net decrease in cash and cash equivalents

(3,534)

(4,313)

(3,581)

Opening cash and cash equivalents

10,056

13,637

13,637

Cash and cash equivalents at period end

6,522

9,324

10,056

 

Notes to the financial statements

 

1. Accounting policies

 

General Information

The half year results for the current and comparative period to 30 June have not been audited or reviewed by auditors pursuant to the Auditing Practices Board guidance of Review of Interim Financial Information.

 

These half year results do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2015 were approved by the Board of Directors on 21 March 2016 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498 of the Companies Act 2006.

 

Having made due enquiries the directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the condensed set of financial statements.

 

The condensed set of financial statements was approved by the Board of directors on 20 September 2016.

 

Basis of preparation

 

Statement of compliance

The half year results for the current and comparative period to 30 June have been prepared in accordance with IAS 34 Interim financial reporting as adopted by the EU and the AIM Rules of UK companies. They do not include all of the information required for full annual financial statements and should be read in conjunction with the financial statements of the Group for the year ended 31 December 2015, which have been prepared in accordance with IFRSs as adopted by the European Union.

 

Use of judgements and estimates

The preparation of financial statements in conformity with IFRSs requires management to make judgements and estimates that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the year in which the estimates are revised and in any future years affected.

 

The preparation of the condensed set of financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

 

In preparing the condensed set of financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were of the same type as those that applied to the financial statements for the year ended 31 December 2015.

 

Significant accounting policies

The accounting policies used in the preparation of these interim financial statements for the 6 months ended 30 June 2016 are the accounting policies as applied to the Group's financial statements for the year ended 31 December 2015.

 

Use of non-GAAP measures

 

Underlying operating profit

The Directors believe that underlying operating profit provides additional useful information for shareholders on underlying trends and performance. This measure is used for performance analysis. Underlying operating profit is not defined by IFRS and therefore may not be directly comparable with other companies' adjusted profit measures. It is not intended to be a substitute for, or superior to, IFRS measurements of operating profit.

 

The adjustments made to reported operating profit are:

 

IFRS 2 Share Based Payments - non-cash Group Income Statement charge for share based payments. IFRS 2 requires the fair value of equity instruments measured at grant date to be spread over the period during which the employees become unconditionally entitled to the options. This is a non-cash charge and has been excluded from underlying operating profit as it does not reflect the underlying performance of the Group.

 

IFRS 3 (Revised) Business Combinations - intangible asset amortisation charges and costs arising from acquisitions. Under IFRS 3 intangible assets are required to be amortised on a straight-line basis over their useful economic life and as such is a non-cash charge that does not reflect the underlying performance of the business acquired. Similarly, the standard requires all acquisition costs to be expensed in the Group Income Statement. Due to their nature, these costs have been excluded from underlying operating profit as they do not reflect the underlying performance of the Group.

 

Other one-off costs - these relate to certain one-off costs associated with the Group's acquisition activities including any costs is relation to aborted acquisitions. These have been excluded from underlying operating profit as they do not reflect the underlying performance of the Group.

 

Adjusted net debt

The Directors believe that the adjusted net debt provides additional useful information for shareholders on underlying trends and performance. This measure is used for performance analysis. Adjusted net debt is not defined by IFRS and therefore may not be directly comparable with other companies' adjusted debt measures. It is not intended to be a substitute for, or superior to, IFRS measurements of net debt. Adjusted net debt comprises cash and cash equivalents, borrowings and other payables relating to a discontinued pre- LASPO product.

 

 

Business combination

Business combinations are accounted for using the acquisition method as at the acquisition date, which is the date on which control is transferred to the Group. The Group measures goodwill as the acquisition-date fair value of the consideration transferred, less the net of the acquisition-date fair values of the identifiable assets acquired and liabilities assumed, including contingent liabilities as required by IFRS 3.

 

Consideration transferred includes the fair values of assets transferred, liabilities incurred by the Group to the previous owners of the acquiree, equity interests issued by the Group, contingent consideration, and share-based payment awards of the acquiree that are replaced in the business combination. Any contingent consideration payable is recognised at fair value at the acquisition date. Subsequent changes to the fair value of contingent consideration that is not classified as equity are recognised in the income statement.

 

Transaction costs that the Group incurs in connection with a business combination, such as finder's fees, legal fees, due diligence fees, and other professional and consulting fees, are expensed as incurred.

 

Goodwill

Goodwill represents the excess of the fair value of the consideration given over the fair value of the Group's share of the net identifiable assets of the acquired subsidiary at the date of acquisition. Goodwill is not amortised but is tested for impairment annually and again whenever indicators of impairment are detected and is carried at cost less any provision for impairment. Any impairment is recognised in the income statement.

 

Other intangible assets

Other intangible assets that are acquired by the Group and have finite useful lives are measured at cost less accumulated amortisation and any accumulated impairment losses.

 

Cost or valuation

Intangible assets arising from a business combination are recognised at fair value, amortised over their estimated useful lives and subject to impairment testing.

 

Amortisation

Intangible assets are amortised on a straight-line basis over their estimated useful lives as follows:

 

Technology related intangibles

-

5 to 10 years

Contract related intangibles

-

5 to 10 years

Brand names

-

5 to 10 years

Other intangibles assets

-

3 years

No amortisation is charged on assets under construction as these are not yet in use.

 

Depreciation

Depreciation is calculated to write off the cost, less estimated residual value, of property, plant and equipment by equal instalments over their estimated useful economic lives as follows:

 

Office equipment

-

3 to 5 years

Computers

-

3 years

 

2. Operating segments

 

Personal Injury

£000

Pre-LASPO ATE

£000

Conveyancing

£000

Critical Care

£000

Other segments

£000

Non underlying items

£000

Total

£000

Period ended 30 June 2016

Revenue

15,864

-

4,655

5,234

-

-

25,753

Depreciation and amortisation

(39)

-

(84)

(18)

(478)

-

(619)

Operating profit/(loss)

7,005

-

685

1,815

(755)

(1,022)

7,728

Financial income

10

-

-

-

-

-

10

Financial expenses

-

-

(2)

(2)

(205)

-

(209)

Profit/(loss) before tax

7,015

-

683

1,813

(960)

(1,022)

7,529

Trade receivables

2,217

-

541

3,510

130

-

6,398

Segment liabilities

(6,508)

(3,167)

(1,298)

(1,131)

(620)

-

(12,724)

Capital expenditure

131

-

5

15

-

-

151

Period ended 30 June 2015

Revenue

23,913

-

1,498

-

-

-

25,411

Depreciation and amortisation

(86)

-

(18)

-

-

-

(104)

Operating profit/(loss)

7,517

-

321

-

(808)

(544)

6,486

Financial income

29

-

-

-

6

-

35

Financial expenses

-

-

-

-

(90)

-

(90)

Profit/(loss) before tax

7,546

-

321

-

(892)

(544)

6,431

Trade receivables

4,911

-

199

-

47

-

5,157

Segment liabilities

(6,669)

(4,610)

(483)

-

(3,003)

-

(14,765)

Capital expenditure

6

-

-

-

-

6

12 months ended 31 December 2015

Revenue

45,081

-

3,522

2,133

-

-

50,716

Depreciation and amortisation

(160)

-

(22)

(5)

(249)

-

(436)

Operating profit/(loss)

15,528

-

825

644

(1,375)

(1,503)

14,119

Financial income

49

-

-

-

10

-

59

Financial expenses

-

-

(2)

-

(226)

-

(228)

Profit/(loss) before tax

15,577

-

823

644

(1,591)

(1,503)

13,950

Trade receivables

2,646

-

215

3,351

-

-

6,212

Segment liabilities

(6,960)

(3,601)

(298)

(884)

(807)

-

(12,550)

Capital expenditure

82

-

113

-

-

-

195

 

Geographic information

All revenue and assets of the Group are based in the UK.

 

Operating segments

The segments used in reporting by the Chief Operating Decision Maker (CODM), being the Board, and considered relevant to the business are segmented on a divisional basis. These segments are:

 

Personal Injury

Revenue from the provision of enquiries to the panel law firms, based on a cost plus margin model, plus commissions received from providers for the sale of additional products by them to the panel law firms.

 

Pre-LASPO ATE

Revenue is commissions received from the insurance provider for the use of 'after the event' policies by panel law firms. From 1 April 2013, this product was no longer available as a result of LASPO regulatory changes. Included in the balance sheet is a liability that has been separately identified due to its material value. This balance is commissions received in advance that are due to be paid back to the insurance provider. No interest is due on this liability.

 

Conveyancing 

Revenue from the provision of online marketing services to target home buyers and sellers in England and Wales, offering lead generation services to panel law firms and surveyors in the conveyancing sector and the provision of conveyancing searches for solicitors and licensed conveyancers.

 

Critical Care 

Revenue from the provision of expert witness reports and case management support within the medico-legal framework for multi-track cases.

 

Other segments

Costs that are incurred in managing Group activities or not specifically related to a division and including share based payments.

 

Non underlying items

Costs associated with the acquisition of subsidiary undertakings, share based payments, amortisation charges on intangible assets recognised as part of business combination and IPO related costs.

 

Cash flows from operating activities

A reconciliation of operating profit to cash generation from operations has been presented below separately identifying net cash flows relating to Continuing operations (comprising cash flows associated with Personal Injury, Conveyancing, Critical Care and other segments), the Pre- LASPO ATE product segment and one-off items.

 

 

Reconciliation of operating profit to net cash flows from operating activities

Continuing operations

£000

Pre-LASPO

ATE

£000

Sub-total

£000

Non underlying

items

£000

Total

£000

6 months ended 30 June 2016

Operating profit

7,784

-

7,784

(56)

7,728

Amortisation on business combination

533

-

533

-

533

Equity-settled share-based payments

433

-

433

-

433

Underlying operating profit

8,750

-

8,750

(56)

8,694

Depreciation and amortisation

86

-

86

-

86

Increase in trade/other receivables

(823)

-

(823)

-

(823)

Increase in trade/other payables

364

-

364

-

364

Decrease in liabilities relating to pre-LASPO ATE product

-

(434)

(434)

-

(434)

Net cash flows from operating activities before interest and tax

8,377

(434)

7,943

(56)

7,887

 

6 months ended 30 June 2015

Operating profit

6,656

-

6,656

(170)

6,486

Amortisation on business combination

-

-

-

-

-

Equity-settled share-based payments

374

-

374

-

374

Underlying operating profit

7,030

-

7,030

(170)

6,860

Depreciation and amortisation

104

-

104

-

104

Increase in trade/other receivables

(1,792)

-

(1,792)

-

(1,792)

Increase in trade/other payables

1,371

-

1,371

9

1,380

Decrease in liabilities relating to pre-LASPO ATE product

-

(1,901)

(1,901)

-

(1,901)

Net cash flows from operating activities before interest and tax

6,713

(1,901)

4,812

(161)

4,651

 

 

 

12 months ended 31 December 2015

Operating profit

14,530

-

14,530

(411)

14,119

Amortisation on business combination

259

-

259

-

259

Equity-settled share-based payments

833

-

833

-

833

Underlying operating profit

15,622

-

15,622

(411)

15,211

Depreciation and amortisation

177

-

177

-

177

Increase in trade/other receivables

(813)

-

(813)

-

(813)

Increase in trade/other payables

226

-

226

-

226

Decrease in liabilities relating to pre-LASPO ATE product

-

(2,910)

(2,910)

-

(2,910)

Net cash flows from operating activities before interest and tax

15,212

(2,910)

12,302

(411)

11,891

 

 

3. Financial income

 

Unaudited 6 months ended 30 June 2016

£000

Unaudited 6 months ended 30 June 2015

£000

Audited 12 months ended 31 December 2015

£000

Bank interest income

10

35

59

Total finance income

10

35

59

 

 

4. Financial expense

 

Unaudited 6 months ended 30 June 2016

£000

Unaudited 6 months ended 30 June 2015

£000

Audited 12 months ended 31 December 2015

£000

On bank loans

209

90

216

Bank charges

-

-

12

Total finance expense

209

90

228

 

 

5. One-off items

Unaudited 6 months ended 30 June 2016

£000

Unaudited 6 months ended 30 June 2015

£000

Audited 12 months ended 31 December 2015

£000

Legal and professional fees relating to acquisitions 1

56

146

570

Vendors consultancy fees on Fitzalan acquisition 2

-

24

24

IPO related costs 3

-

-

(183)

Total finance expense

56

170

411

 

1. Legal and professional fees paid in relation to the acquisitions of Searches UK, Fitzalan Partners, BVC and Bush & Company Rehabilitation, including due diligence costs and stamp duty.

2. Fees paid to former senior management of Fitzalan Partners for consultancy services provided in the business post acquisition.

3. Previously recognised cost accruals in respect of the IPO of £183,000 were released in the year.

 

6. Acquisitions

 

Acquisition of Searches UK Limited

On 11 January 2016 the Group acquired the entire share capital of Searches UK Limited. The company is a leading conveyancing search provider in England & Wales predominantly for residential property transactions.

 

Acquisition of Bush & Company Rehabilitation Limited

On 14 October 2015 the Group acquired the entire share capital of Bush & Company Rehabilitation Limited. The company provides expert witness reports and case management support within the medico-legal framework for multi-track cases.

 

Acquisition of Best Value Conveyancing

On 30 June 2015, Fitzalan acquired the trading assets of Best Value Conveyancing (BVC). BVC provides lead generation services to law firms in the conveyancing sector.

 

Acquisition of Fitzalan Partners Limited

On 17 February 2015 the Group acquired the entire share capital of Fitzalan Partners Limited. The company is an online marketing specialist servicing home buyers and sellers in England and Wales. The acquisition of Fitzalan represents the Group's first move into an adjacent consumer legal services market.

 

 

Fair values

The acquisitions had the following effect on the Group's assets and liabilities:

 

 

Unaudited 6 months ended 30 June 2016

£000

Unaudited 6 months ended 30 June 2015

£000

Audited 12 months ended 31 December 2015

£000

Intangible assets

881

502

8,662

Tangible assets

6

-

53

Trade and other receivables

367

141

3,503

Cash and cash equivalents

293

626

5,572

Trade and other payables

(415)

(463)

(1,676)

Deferred tax liability

(176)

(101)

(1,738)

Net assets acquired

956

705

14,376

Goodwill arising on acquisition

1,124

3,829

19,341

Fair value of net assets acquired and goodwill arising

2,080

4,534

33,717

Cash consideration

2,080

3,662

32,274

Fair value of deferred consideration

-

872

1,443

Fair value of net assets acquired and goodwill arising

2,080

4,534

33,717

 

 

The Group incurred acquisition related costs of £56,000 (H1 2015: £146,000, Full Year 2015: £570,000) related to professional fees paid for due diligence, general professional fees and legal related costs. These costs have been included in one off items in the Group's consolidated income statement.

 

At 31 December 2015, £36,000 of deferred consideration remained outstanding in respect of the BVC acquisition, as at 30 June 2016, the final amount was settled at £11,000, with the resulting £25,000 of the deferred consideration being released.

 

For all acquisitions made in the year, fair values remain provisional, but will be finalised within 12 months of acquisition.

 

7. Goodwill

 

Personal Injury

£000

Conveyancing

£000

Critical Care

£000

Total

£000

Cost

At 30 June 2015

39,897

3,829

-

43,726

At 30 December 2015

39,897

3,749

15,592

59,238

Acquired through business combination

-

1,124

-

1,124

At 30 June 2016

39,897

4,873

15,592

60,362

Impairment

At 30 June 2015

-

-

-

-

At 30 December 2015

-

-

-

-

At 30 June 2016

-

-

-

-

Net book value

At 30 June 2015

39,897

3,829

-

43,726

At 30 December 2015

39,897

3,749

15,592

59,238

At 30 June 2016

39,897

4,873

15,592

60,362

 

8. Intangibles

 

Technology related

£000

Contract related

£000

Brand names

£000

Other

£000

Assets under construction

£000

Total

£000

Cost

At 30 June 2015

167

185

150

-

-

502

At 31 December 2015

167

7,746

749

47

4

8,713

Additions

-

-

-

10

4

14

Acquisitions through business combination

-

720

136

-

-

856

At 30 June 2016

167

8,466

885

57

8

9,583

Amortisation

At 30 June 2015

6

12

-

-

-

18

At 31 December 2015

22

214

23

2

-

261

Amortisation charge on business combination

10

474

49

-

-

533

Amortisation charge for the period

-

-

-

9

-

9

At 30 June 2016

32

688

72

11

-

803

Net book value

At 30 June 2015

161

173

150

-

-

484

At 31 December 2015

145

7,532

726

45

4

8,452

At 30 June 2016

135

7,778

813

46

8

8,780

 

The intangible assets recognised were acquired as part of the acquisitions of Fitzalan, BVC, Bush and Searches UK.

 

9. Share capital

 

30 June 2016

30 June 2015

31 December 2015

Number of shares

'A' Ordinary Shares of £0.0025 each

45,270,937

41,150,000

45,265,000

£000

£000

£000

Allotted, called up and fully paid

'A' Ordinary Shares of £0.0025 each

113

103

113

Shares classified in equity

113

103

113

 

10. Transactions with owners, recorded directly in equity

 

On 13 May 2016, 5,937 new ordinary shares with a par value of £0.0025 were issued due to the exercising of equity settled share based payments in respect of the SAYE scheme. These raised an additional £9,499 of funds for the Company, resulting in an increase to share premium of £9,484 and share capital of £15.

 

11. Basic earnings per share

 

The calculation of basic earnings per share at 30 June 2016 is based on profit attributable to ordinary shareholders of £5,966,000 (H1 2015: £5,144,000; Full Year 2015: £10,766,000) and a weighted average number of Ordinary Shares outstanding of 45,266,598 (June 2015: 41,150,000; December 2015: 42,040,643).

 

Profit attributable to ordinary shareholders (basic)

 

Unaudited 6 months ended 30 June

2016

£000

 

Unaudited 6 months ended 30 June

2015

£000

 

Audited 12 months ended 31 December 2015

£000

Profit for the period / year attributable to the shareholders

5,966

5,144

10,766

 

Weighted average number of Ordinary Shares (basic)

Number

 

 

 

Note

 

Unaudited 6 months ended

30 June 2016

 

Unaudited 6 months ended 30 June 2015

Audited 12 months ended 31 December 2015

Issued Ordinary Shares at start of period

9

45,265,000

41,150,000

41,150,000

Weighted average number of Ordinary Shares at end of period

9

45,266,598

41,150,000

42,040,643

 

Basic earnings per share (p)

Unaudited 6 months ended 30 June 2016

Unaudited 6 months ended 30 June 2015

Audited 12 months ended 31 December 2015

Basic earnings per share (p)

13.2

12.5

25.6

 

The Company has in place share-based payment schemes to reward employees. At the 30 June 2016, the LTIP, EMI and SAYE schemes are at a value that would reasonably result in the options being exercised. The incremental shares available for these schemes included in the diluted earnings per share calculation are 969,707 (June 2015: 693,609; December 2015: 938,719). There are no other diluting items.

 

Diluted earnings per share (p)

Unaudited 6 months ended 30 June 2016

Unaudited 6 months ended 30 June 2015

Audited 12 months ended 31 December

 2015

Diluted earnings per share (p)

12.9

12.3

25.0

 

 

12. Financial risk management

 

The Group's financial risk management objectives and policies are consistent with those disclosed in the financial statements for the year ended 31 December 2015. At 1 January 2016 and 30 June 2016 the Group held all financial instruments at Level 3 (as defined in IFRS 7 Financial instruments: disclosures) and there have been no transfers of assets or liabilities between levels of the fair value hierarchy.

 

13. Net (debt)/cash

 

Net (debt)/cash included cash and cash equivalents, secured bank loans, loan notes and preference shares.

 

 30 June 2016

£000

 30 June 2015

£000

31 December 2015

£000

Cash and cash equivalents

6,522

9,324

10,056

Other interest-bearing loans and loan notes

(12,936)

(5,901)

(14,782)

Net (debt)/cash

(6,414)

3,423

(4,726)

 

Set out below is a reconciliation of movements in net cash during the period.

30 June 2016

£000

30 June 2015

£000

31 December 2015

£000

Net decrease in cash and cash equivalents

(3,534)

(4,313)

(3,581)

Cash and cash equivalents net inflow from increase in debt and debt financing

1,846

-

(8,881)

Movement in net borrowings resulting from cash flows

(1,688)

(4,313)

(12,462)

Movement in cash in period

(1,688)

(4,313)

(12,462)

Net (debt)/cash at beginning of period

(4,726)

7,736

7,736

Net (debt)/cash at end of period

(6,414)

3,423

(4,726)

 

14. Related parties

 

Transactions with key management personnel

 

Key management personnel in situ at 30 June 2016 and their immediate relatives control 4.7 per cent (June 2015: 6.3 per cent, December 2015: 4.8 per cent) of the voting shares of the Company.

 

Key management personnel are considered to be the Directors of the Company as well as those of National Accident Helpline Limited, Fitzalan Partners Limited, Bush & Company Rehabilitation Limited, Searches UK Limited and any other management serving as part of the Executive Team.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EAKNEAALKEFF
Date   Source Headline
5th Apr 20241:51 pmRNSHolding(s) in Company
5th Apr 202412:19 pmRNSResponse to speculation
8th Mar 20247:00 amRNSRenewal of Banking Facilities
24th Jan 20247:00 amRNSYear End Trading Update
30th Oct 20237:00 amRNSGrant of options under SAYE Scheme
19th Oct 20236:07 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotice of Results and Investor Presentation
31st Jul 20235:00 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf Year Trading Update
2nd Jun 20235:24 pmRNSDirector/PDMR Shareholding
31st May 20235:00 pmRNSTotal Voting Rights
31st May 20233:50 pmRNSIssue of Equity and Total voting rights
25th May 20231:50 pmRNSHolding(s) in Company
25th May 20231:19 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
19th May 20233:16 pmRNSIssue of Equity from Exercise of Share Options
18th May 20237:49 amRNSHolding(s) in Company
2nd May 202312:57 pmRNSGrant of Awards under Group Share Option Plan
28th Apr 20238:28 amRNSAnnual Report & Accounts and Notice of AGM
25th Apr 20237:00 amRNSSale of Homeward Legal
24th Apr 20232:43 pmRNSHolding(s) in Company
24th Mar 20234:59 pmRNSFinal Results – replacement
22nd Mar 20237:00 amRNSFinal Results
16th Mar 20237:00 amRNSNotice of Investor Presentation
24th Jan 20237:00 amRNSYear End Trading Update and Notice of Results
5th Dec 20222:42 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
22nd Sep 20227:00 amRNSNotice of Results and Investor Presentation
15th Sep 20227:00 amRNSDirectorate changes
2nd Aug 20221:15 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSHalf Year Trading Update
14th Jul 20221:58 pmRNSHolding(s) in Company
7th Jul 20224:44 pmRNSHoldings in Company
15th Jun 202212:13 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
10th May 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSGrant of Awards under Group Share Option Plan
29th Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSNotice of Investor Presentation
11th Feb 20227:00 amRNSChange of Nominated Adviser and Broker
19th Jan 20227:00 amRNSTrading Update and Revised Banking Facility
5th Jan 20225:02 pmRNSHolding(s) in Company
9th Dec 20217:00 amRNSIssue of Equity from Exercise of Share Options
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20217:00 amRNSNotice of Investor Presentation
26th Aug 20214:41 pmRNSSecond Price Monitoring Extn
26th Aug 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.